Patents Assigned to EASTGATE PHARMACEUTICALS INC.
  • Pharmaceutical composition for transmucosal delivery and methods for treating diabetes in a subject in need thereof
    Patent number: 10568936
    Abstract: The present disclosure relates to pharmaceutical compositions of solid dosage form for intraoral administration that provides effective delivery of insulin and insulin analogs via the transmucosal route. Also provided are methods for treating pre-diabetes, diabetes and metabolic syndrome in a subject in need thereof.
    Type: Grant
    Filed: March 4, 2015
    Date of Patent: February 25, 2020
    Assignee: EASTGATE PHARMACEUTICALS INC.
    Inventors: Joseph Schwarz, Michael Weisspapir